J4P-15377-62192
4 vaccinations
1 coded response
52 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 497 / MI
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Pfizer-BioNTech
- 2021-01-04
- 2021-01-06
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains · Be unable to workAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-13
- 2021-01-18
-
2021-01-25
Dose 2 — Pfizer-BioNTech
- 2021-01-25
-
2021-01-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-27
- 2021-01-28
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-04-26
- 2021-07-26
-
2021-11-11
Dose 3 — Pfizer-BioNTech
- 2021-11-11
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-15
-
2021-11-16
Survey response — days 1–6 daily, dose 3MedDRA: Respiratory tract congestion — Feeling: Fair · Fatigue or tirednessFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Joint pains · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-18
Health check-in — day 7, dose 3Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-16
- 2021-12-23
- 2022-02-10
- 2022-05-12
-
2022-11-06
Dose 4 — Pfizer-BioNTech
- 2022-11-07
- 2022-11-08
- 2022-11-09
- 2022-11-10
- 2022-11-11
- 2022-11-12
- 2022-11-13
- 2022-11-20
- 2022-11-29
- 2022-12-04
- 2022-12-11
- 2022-12-18
- 2023-02-05
- 2023-05-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Pfizer-BioNTech | |
| 2 | 2021-01-25 | Pfizer-BioNTech | |
| 3 | 2021-11-11 | Pfizer-BioNTech | No |
| 4 | 2022-11-06 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release